People

Dr. Kenneth Croitoru joined the Division of Gastroenterology at Mount Sinai Hospital in January 2008. He completed medical school at McGill University in 1981 and then trained in internal medicine and gastroenterology from 1982-1986. He went on to do post-doctoral training as an MRC Research Fellow in Mucosal Immunology with Dr. John Bienenstock at McMaster University. On completion of this research training he joined the Division of Gastroenterology at McMaster in 1992 where he went on to serve as Training Program Director and Associate Director of the Division. During this time he developed his research program with funding from the Canadian Institute of Health Research, Canadian Association of Gastroenterology and the Crohn’s and Colitis Foundation of Canada. He held an Ontario Ministry of Health Career Scientist award for 10 years and more recently was one of the first recipients of a 5 year CCFC IBD Research Scientist Award. He served as the Chair of the CCFC Medical Advsiory Board and helped develop the CCFC IBD Research Institute where he served as Chair of the Executive Committee until 2008. Dr. Croitoru joined the Department of Medicine at Mount Sinai Hospital as a Clinician Scientist and is a full Professor of Medicine at the University of Toronto In 2008. His research is focused on investigating the fundamental mechanisms of intestinal inflammation, in particular the role of T cell effector and regulatory function in the intestinal mucosal in Inflammatory Bowel Disease. These studies will be carried out at the Medical Sciences Building at the University of Toronto, where he is a member of the Institute of Medical Sciences and is secondarily appointed to the Department of Immunology. Dr. Croitoru is also Project Leader of, the GEM Project (www.GEMPROJECT.ca) a global clinical study that is coordinated out of the IBD Research Group and Zane Cohen Center at Mount Sinai Hospital. The study is a prospective cohort study of healthy subjects at risk of developing Crohn's disease. That will explore the Genetic, Environmental and Microbial factors that lead to Cohn's disease. This study has had over $15 million in funding from Crohn's Colitis Canada, CIHR and the Helmsley Charitable Trust.